Results 121 to 130 of about 1,828,177 (366)
Evolving practice - The environment court of New Zealand [PDF]
, 2005 Practice before the Environment Court is evolving. Recent innovations have included enhanced support for Judges through the appointment of case managers and hearings managers, digital recording of evidence, provision for Commissioner only hearings, the ...
Daya-Winterbottom, Trevor
core +1 more source
Molecular Oncology, EarlyView.In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim +11 more
wiley +1 more source
Revista Chilena de Derecho, 2011 El presente comentario tiene por objeto revisar la figura del perito y la objetividad e imparcialidad que deben regir los dictámenes que emita, con la finalidad de colaborar con el órgano jurisdiccional en la búsqueda de la verdad acerca de los hechos ...
Maite Aguirrezabal Grünstein
doaj
[The radiological expert witness report-a beginner's guide]. [PDF]
Radiologe, 2022 Sigl B, Meickmann T, Herold C.
europepmc +1 more source
Expert Eyewitness Testimony [PDF]
, 2006 This paper will illustrate how the problem of wrongful convictions based on mistaken identifications in New York can be overcome by altering the investigative procedures implemented by police departments and making better use of effective trial ...
Kovacs, Janine M.
core +1 more source
Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management
Molecular Oncology, EarlyView.DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez +5 more
wiley +1 more source
EXPERTISE OF THE EXPERT MEDICAL WITNESS IN CONGENITAL MALFORMATION LAWSUITS [PDF]
, 1977 Robert L. Brent
openalex +1 more source
ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma
Molecular Oncology, EarlyView.In SMAD4‐positive pancreatic ductal adenocarcinoma (PDAC), integrin subunit alpha V (ITGAV) activates latent TGF‐β, which binds to the TGF‐β receptor and phosphorylates SMAD2/3. The activated SMAD2/3 forms a complex with SMAD4, and together they translocate to the nucleus, modulating gene expression to promote proliferation, migration, and invasion. In
Daniel K. C. Lee +9 more
wiley +1 more source
Molecular Oncology, EarlyView.This study presents a novel AI‐based diagnostic approach—comprehensive serum glycopeptide spectra analysis (CSGSA)—that integrates tumor markers and enriched glycopeptides from serum. Using a neural network model, this method accurately distinguishes liver and pancreatic cancers from healthy individuals.
Motoyuki Kohjima +6 more
wiley +1 more source
The expert witness in child abuse and neglect: An interdisciplinary process [PDF]
, 1981 Donald N. Duquette
openalex +1 more source